FDNA launches Face2Gene LABS to accelerate genetic disease diagnoses
The company is teaming-up with two of the most reputable genomics testing labs in the world - GeneDx and Blueprint Genetics.
Genomics
PatientsLikeMe, Shire working together to study rare genetic diseases
The multi-year deal involves the two companies working together to engage patients and caregivers at every stage of their journey.
FDA greenlights 23andMe's request to market direct-to-consumer genetic health risk reports
Genetic risk reports for Alzheimer's disease, Parkinson's disease and Hereditary Thrombophilia included in the FDA authorization, among others.
FDNA's Face2Gene RESEARCH uses computer vision to accelerate genomic discoveries
The application enables clinicians all around the world to make rare and genetic disease discoveries using deep learning and artificial intelligence.
NantHealth looking to raise $92M in an IPO
The Culver City, California-based company has developed a platform, called CLINICS, to address many of the key challenges healthcare constituents face.
Mayo Clinic, GE Ventures to bring IoT to cell and gene therapies
Vitruvian Networks, will serve as a network orchestrator for therapeutic companies with powerful business intelligence and data analytics capabilities.
Trial to use genetic data, sensors to diagnose Parkinson's disease
Called GADGET-PD, the trial will use wireless sensors and genetic sequencing to determine if a patient has essential tremor (ET) from Parkinson's disease (PD).
Apple ResearchKit updated with support for genetic data
Researchers are now able to design targeted studies for diseases and conditions, and to gather more specific types of data from participants.
Tute Genomics acquires Knome to boost its genomics tech
Knome's knoSYS tech brings maximum value to the already robust genome informatics offerings at Tute, used by many of the top institutions across the world.
23andMe launches new FDA-cleared service
Called Personal Genome Service, it is touted as an entirely new experience that includes carrier status, wellness, trait and ancestry reports.